Bessemer Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.06M Buy
39,270
+3,276
+9% +$292K 0.01% 642
2026
Q1
$2.58M Buy
35,994
+9,320
+35% +$718K ﹤0.01% 745
2025
Q4
$2.12M Sell
26,674
-444
-2% -$35K ﹤0.01% 807
2025
Q3
$2.05M Buy
27,118
+3,933
+17% +$270K ﹤0.01% 496
2025
Q2
$1.6M Sell
23,185
-3,963
-15% -$260K ﹤0.01% 515
2025
Q1
$1.84M Sell
27,148
-39,469
-59% -$2.36M ﹤0.01% 497
2024
Q4
$2.99M Buy
66,617
+429
+0.6% +$24.1K ﹤0.01% 564
2024
Q3
$4.16M Sell
66,188
-3,914
-6% -$228K 0.01% 473
2024
Q2
$4.14M Sell
70,102
-3,241
-4% -$203K 0.01% 394
2024
Q1
$5.85M Buy
73,343
+26,173
+55% +$2M 0.01% 365
2023
Q4
$3.72M Buy
47,170
+4,270
+10% +$304K 0.01% 402
2023
Q3
$3M Sell
42,900
-5,311
-11% -$376K 0.01% 411
2023
Q2
$3.33M Buy
48,211
+2,339
+5% +$166K 0.01% 408
2023
Q1
$3.41M Buy
45,872
+1,236
+3% +$104K 0.01% 388
2022
Q4
$4.16M Sell
44,636
-1,752
-4% -$169K 0.01% 355
2022
Q3
$4.42M Buy
46,388
+433
+0.9% +$42.9K 0.01% 334
2022
Q2
$4.26M Buy
45,955
+2,447
+6% +$239K 0.01% 322
2022
Q1
$4.4M Buy
43,508
+6,769
+18% +$711K 0.01% 261
2021
Q4
$3.79M Buy
36,739
+14,188
+63% +$1.31M 0.01% 268
2021
Q3
$1.91M Buy
22,551
+3,786
+20% +$317K ﹤0.01% 317
2021
Q2
$1.57M Buy
18,765
+574
+3% +$47K ﹤0.01% 353
2021
Q1
$1.37M Sell
18,191
-2,027
-10% -$148K ﹤0.01% 368
2020
Q4
$1.38M Sell
20,218
-1,152
-5% -$74.9K ﹤0.01% 355
2020
Q3
$1.25M Sell
21,370
-18,319
-46% -$1.14M ﹤0.01% 374
2020
Q2
$2.58M Buy
39,689
+26,027
+191% +$1.64M 0.01% 420
2020
Q1
$812K Buy
13,662
+1,681
+14% +$112K ﹤0.01% 657
2019
Q4
$890K Buy
11,981
+451
+4% +$31.7K ﹤0.01% 762
2019
Q3
$728K Sell
11,530
-3,327
-22% -$197K ﹤0.01% 776
2019
Q2
$810K Sell
14,857
-5,458
-27% -$294K ﹤0.01% 750
2019
Q1
$1.1M Sell
20,315
-2,547
-11% -$157K ﹤0.01% 611
2018
Q4
$1.5M Buy
22,862
+9,935
+77% +$742K 0.01% 472
2018
Q3
$1.02M Buy
12,927
+1,968
+18% +$141K ﹤0.01% 578
2018
Q2
$705K Sell
10,959
-1,209
-10% -$79.7K ﹤0.01% 666
2018
Q1
$757K Sell
12,168
-76
-0.6% -$5.45K ﹤0.01% 646
2017
Q4
$888K Buy
12,244
+173
+1% +$12.6K ﹤0.01% 645
2017
Q3
$982K Sell
12,071
-7,456
-38% -$590K ﹤0.01% 664
2017
Q2
$1.57M Sell
19,527
-72,025
-79% -$5.69M 0.01% 535
2017
Q1
$7.19M Sell
91,552
-1,812,469
-95% -$145M 0.03% 274
2016
Q4
$150M Sell
1,904,021
-167,140
-8% -$13.5M 0.69% 47
2016
Q3
$184M Buy
2,071,161
+10,396
+0.5% +$981K 0.93% 24
2016
Q2
$197M Buy
2,060,765
+237,251
+13% +$23.6M 1.08% 14
2016
Q1
$189M Buy
1,823,514
+45,247
+3% +$4.4M 1.07% 17
2015
Q4
$174M Buy
1,778,267
+254,169
+17% +$24.9M 0.97% 23
2015
Q3
$147M Buy
1,524,098
+284,883
+23% +$29.9M 0.84% 29
2015
Q2
$130M Buy
1,239,215
+7,508
+0.6% +$767K 0.68% 49
2015
Q1
$127M Buy
1,231,707
+22,945
+2% +$2.32M 0.64% 60
2014
Q4
$116M Sell
1,208,762
-365
-0% -$32.2K 0.63% 58
2014
Q3
$96.2M Buy
1,209,127
+16,155
+1% +$1.27M 0.55% 66
2014
Q2
$89.9M Buy
1,192,972
+14,742
+1% +$1.11M 0.55% 69
2014
Q1
$88M Sell
1,178,230
-425,846
-27% -$30.1M 0.59% 66
2013
Q4
$115M Buy
1,604,076
+51,661
+3% +$3.32M 0.82% 43
2013
Q3
$88.1M Buy
1,552,415
+46,277
+3% +$2.76M 0.71% 67
2013
Q2
$86.1M Buy
+1,506,138
New +$87.3M 0.77% 60

Other funds holding CVS

Bessemer Group's CVS Position: Q2 2026 in Review

Bessemer Group increased its CVS Health (CVS) stake by 9.1% in Q2 2026, buying an estimated $292K and bringing the position to 39,270 shares worth $4.06M. The position accounts for 0.01% of the portfolio, ranked #642.

Bessemer Group first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $197M in Q2 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bessemer Group held 39,270 shares of CVS Health worth $4.06M as of Q2 2026.
  • Bessemer Group bought 3,276 CVS Health shares in Q2 2026, an estimated $292K.
  • CVS Health made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #642 holding.
  • Bessemer Group first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Bessemer Group's CVS Health position peaked at $197M in Q2 2016.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.